As of Dec 02
| +0.16 / +0.29%|
The 23 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 61.00, with a high estimate of 100.00 and a low estimate of 44.20. The median estimate represents a +9.01% increase from the last price of 55.96.
The current consensus among 25 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.